In this thesis we describe the advantages of using laser capture microdissection combined with Mass spectrometry technology to find potential candidate biomarkers for diagnostic and prognostic purposes in two diseases, preeclampsia and cervical cancer.
We present both a bottom up and a targeted proteomics technique using affected tissue followed by validation in biomaterial for preeclampsia and cervical cancer, respectively